PetCaseFinder

Peer-reviewed veterinary case report

Baerveldt implant surgery results in 17 dogs with closed-angle

By Crowe, Yvette C et al.·Published in Veterinary ophthalmology·2021·Small Animal Specialist Hospital, Australia·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Outcomes of baervedlt implant surgery in 17 dogs (20 eyes) with primary closed-angle glaucoma (2013-2019).

Species:
dog

Plain-English summary

A group of 17 dogs with primary closed-angle glaucoma (PCAG) underwent Baerveldt implant surgery to help manage their eye pressure and preserve vision. After three months, 75% of the treated eyes had normal eye pressure, and 70% still had some vision. However, complications were common, with 80% of the eyes experiencing at least one issue, such as temporary high eye pressure or cataracts. Despite these challenges, the surgery was generally effective in controlling eye pressure and maintaining vision for many dogs over the follow-up period.

People also search for: dog glaucoma surgery outcomes · Baerveldt implant for dogs · dog eye pressure treatment · complications after dog eye surgery · managing dog cataracts

Abstract

OBJECTIVE: To report outcomes and follow-up of Baerveldt implant surgery&#x202f;in dogs with primary closed-angle glaucoma (PCAG). MATERIALS AND METHODS: Record review of client-owned dogs with PCAG that underwent Baerveldt implant surgery during a 6-year period. Postoperative intraocular pressure (IOP), vision and daily number of anti-glaucoma drops at fixed time points (3, 12, and 24&#xa0;months) were compared with preoperative values; complications were recorded. Success was defined as IOP <20&#xa0;mm&#xa0;Hg and a positive menace response and navigation/tracking ability. RESULTS: Twenty eyes (17 dogs) were included. Mean follow-up was 575&#xa0;days (range 30-1767&#xa0;days) from implant surgery to last examination. Three months postoperatively 15/20 (75%) eyes had IOP <20&#xa0;mm&#xa0;Hg and 14/20 (70%) eyes had vision. Twelve months postoperatively 11/17 (65%) eyes had IOP <20&#xa0;mm&#xa0;Hg and 12/19 (63%) eyes had vision. Twenty-four months postoperatively 8/14 (57%) eyes had IOP <20&#xa0;mm&#xa0;Hg and 7/15 (47%) eyes had vision. Denominators differ between time points as eyes were included when duration after surgery reached the relevant postoperative time point or failure was documented earlier. Within 3&#xa0;months postoperatively 16/20 (80%) eyes had &#x2265;1 complication, including transient IOP >20&#xa0;mm&#xa0;Hg (14/20; 70% eyes), fibrin (12/20; 60% eyes), and hypotony (4/20; 20% eyes). After 3&#xa0;months, postoperatively 13/16 (81%) eyes had &#x2265;1 complication, including cataracts (13/16; 81% eyes), bleb fibrosis (3/16; 19% eyes), and conjunctival wound breakdown (1/16; 6% eyes). One patient (1 eye) was euthanized for blindness and 5/20 (25%) eyes were enucleated. CONCLUSIONS: The technique was effective in controlling IOP and maintaining vision in most dogs in this study.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/33609423/